Patient burden in clinical trials remains one of the biggest challenges for the life sciences industry to address. Patient retention and adherence are crucial in the clinical trial process and can dramatically impact the outcome of the trial. Dropout rates are sometimes over 30%, leading to trial delay, additional costs, risk to the validity of the study, and potential failure of the trial. By lessening the burden on trial participants and ensuring they are engaged in the study, dropout rates can be significantly reduced, and patients can generally have a more positive experience. It’s therefore essential that trials are designed with patient centricity at top of mind.